Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup

Ludwig, Heinz;Dimopoulos, Meletios A.;Moreau, Philippe;Chng, Wee Joo;Goldschmidt, Hartmut;Hájek, Roman;Facon, Thierry;Pour, Ludek;Niesvizky, Ruben;Oriol, Albert;Rosiñol, Laura;Suvorov, Aleksandr;GAIDANO, Gianluca;Pika, Tomas;Weisel, Katja;Goranova Marinova, Vesselina;Palumbo, Antonio;Gillenwater, Heidi H.;Mohamed, Nehal;Aggarwal, Sanjay;Feng, Shibao;Joshua, Douglas

2017-01-01